BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. NVDA
2. HD
3. AMLX
4. METC
5. SPY
6. DOO
7. ARGX
8. KLAR
9. INFQ

Go back to BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor
(NASDAQ: BGNE) Delayed: 184.71 --0 (-0%)
Previous Close $184.71    52 Week High $36.76 
Open $184.71    52 Week Low $22.51 
Day High $184.71    P/E N/A 
Day Low $184.71    EPS $0.00 
Volume 3,520,133